Biopsy Devices | Market Insights | Europe (Supplemental) | 2022
Procedure deferrals due to the COVID-19 pandemic severely impacted the European biopsy device market in 2020. Nonetheless, following short-term disruption due to the global pandemic, the European biopsy device market will grow slightly through 2030, driven largely by growth in the percutaneous soft tissue biopsy device market. In addition, the ongoing shift from reusable to disposable devices, coupled with improved patient perceptions surrounding biopsy procedures and screening tests, will have a significant positive impact on the market; overall, these factors will support continued market growth during the forecast period.
This Medtech 360 Report provides high-level market metrics for biopsy devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across an 11-year period.
